The impact of the molecular genetic test on the diagnosis delay and outcome in patients with pulmonary tuberculosis

Journal Title: Moldovan Medical Journal - Year 2018, Vol 61, Issue 3

Abstract

Background: The aim of the study was the assessment of the impact of the molecular genetic Xpert MTB/Rif assay on the diagnostic delay and the treatment effectiveness in pulmonary tuberculosis, according to the results of the microbiological and molecular-genetic methods, in order to optimize the management of the drug resistant tuberculosis. Material and methods: A retrospective selective study, which included 226 patients with multidrug-resistant pulmonary tuberculosis (study sample) and 78 patients with drug-susceptible pulmonary tuberculosis (control group), was performed. Patients were divided into 2 subgroups following the results of the molecular-genetic and bacteriological investigations. The study sample was divided in two groups: the 1st group included 85 patients enrolled in the treatment for drug resistant tuberculosis, according to the results of the Xpert MTB test and the 2nd group included 141 patients enrolled in the treatment DOTS plus, according to the results of the conventional cultures. Results: The impact of the molecular genetic GeneXpert MTB/Rif assay was demonstrated on early diagnosis, adequate treatment according to the drug susceptibility to rifampicin, shorter duration of the treatment, low rate of the side events, optimal treatment compliance and higher treatment effectiveness. The conventional microbiological methods contributed to the late diagnosis of the patients, high rate of the severe and complicated tuberculosis, long duration of the treatment which were reflected on the low treatment effectiveness. However the conventional culture methods allowed the treatment individualization according to the drug susceptibility tests. Conclusions: Target screening of the population with risks and compulsory investigation by GeneXpert MTB/Rif assay will diminish the rate of severe late detected forms of pulmonary tuberculosis and adapt the treatment according to the drug resistance to rifampicin.

Authors and Affiliations

Alina Malic

Keywords

Related Articles

Correlation between spinal nerves, anterolateral abdominal wall muscle tone and inguinal hernia

Background: The complete diagnosis of pathomorphological disorders in case of diseases of the spine determines the choice of effective treatment, pathogenetically argued in various diseases which, according to modern cla...

Mortality through associated illnesses in tuberculosis patients and post-mortem pulmonary tuberculosis diagnosis in Chisinau

Background: The main cause of death of tuberculosis patients is the progression of tuberculosis, but the presence of associated diseases decreases the outcome of treatment of both the underlying and the associated diseas...

Markers of apoptosis and oxidative stress in congestive heart failure

Background: The aim of this work is to study the markers of apoptosis (granzyme B) and oxidative stress (nitric oxide), as well as indicators of endothelial damage - cystatin C and lipid metabolism in patients with conge...

Informing national salt reduction strategy

Background: Excessive salt intake is associated with noncommunicable diseases, especially with hypertension, cardiovascular disease and stroke. Implementation of comprehensive and effective strategies can reduce salt int...

Pharmacists’ role in managing food supplements

Background: Every year, the value of the world market of Food Supplements (FS) increases considerably, especially following the accepting the role of nutrition in maintaining health. The share of official importers of me...

Download PDF file
  • EP ID EP480538
  • DOI 10.5281/zenodo.1299018
  • Views 373
  • Downloads 0

How To Cite

Alina Malic (2018). The impact of the molecular genetic test on the diagnosis delay and outcome in patients with pulmonary tuberculosis. Moldovan Medical Journal, 61(3), 3-9. https://www.europub.co.uk/articles/-A-480538